CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
Stock Stats
News
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market [Yahoo! Finance]
BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market [Globe and Mail, The (Toronto, Canada)]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock, down previously from $75.00.
Form ARS Corbus Pharmaceuticals For: Dec 31
Form DEFA14A Corbus Pharmaceuticals
Form DEF 14A Corbus Pharmaceuticals For: May 15
Form 8-K Corbus Pharmaceuticals For: Mar 20
Form 3 Corbus Pharmaceuticals For: Mar 13 Filed by: Hodgson Ian
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.